CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts Annotations Abstract Library Committee Members
 
HBV | Abstract Library
Abstract Library
 
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
1.Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B
 

Viruses. 2023 Apr 18;15(4):997. doi: 10.3390/v15040997.

Young-Suk Lim 1, W Ray Kim 2, Douglas Dieterich 3, Jia-Horng Kao 4 5, John F Flaherty 6, Leland J Yee 6, Lewis R Roberts 7, Homie Razavi 8, Patrick T F Kennedy 9
 
2.Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis
 

 Surg Res. 2023 Mar;283:1078-1090. doi: 10.1016/j.jss.2022.10.078.Epub 2022 Dec 15.

Colin C Yost 1, Diana C Jimenez 1, Matthew P Weber 1, Elizabeth J Maynes 1, Katherine A Belden 2, Vakhtang Tchantchaleishvili 1, H Todd Massey 1, David A Sass 3, J Eduardo Rame 4, John J Zurlo 2, Nana Aburjania 5
 
3.Transplanting hepatitis B surface antigen-positive livers in the United States: outcomes and opportunities
 

Am J Transplant. 2023 Apr 26;S1600-6135(23)00428-8. doi: 10.1016/j.ajt.2023.04.024.Online ahead of print.

Anshul Bhatnagar 1, Sameer Prakash 2, Peter Lymberopoulos 3, Cameron Goff 1, Anjiya Shaikh 4, Donghee Kim 5, Aijaz Ahmed 5, Carl Berg 6, Susanna Naggie 7, Fasiha Kanwal 8, George Cholankeril 9, Tzu-Hao Lee 10
 
4.Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease
 

Clin Gastroenterol Hepatol. 2023 Mar 31;S1542-3565(23)00233-1.doi: 10.1016/j.cgh.2023.03.025. Online ahead of print.

Jessica A Ulrich 1, Nawras W Habash 1, Yasmine A Ismail 1, William J Tremaine 2, Amy L Weaver 3, Joseph A Murray 2, Edward V Loftus Jr 2, Imad Absah 4
 
5.Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial
 

Ann Hepatol. 2023 Mar-Apr;28(2):100891.doi: 10.1016/j.aohep.2022.100891. Epub 2022 Dec 24.

Roseane P Medeiros 1, Norah A Terrault 2, Daniel F Mazo 1, Claudia P Oliveira 1, Jennifer Dodge 3, Patricia M Zitelli 1, Marta H Lopes 1, Flair J Carrilho 1, Mário G Pessoa 4
 
6.The Global Burden of Liver Disease
 

Clin Gastroenterol Hepatol. 2023 Apr 28;S1542-3565(23)00315-4.doi: 10.1016/j.cgh.2023.04.015. Online ahead of print.

Zobair M Younossi 1, Grace Wong 2, Quentin M Anstee 3, Linda Henry 4
 
7.Prevention of Perinatal Hepatitis B Transmission
 

Obstet Gynecol Clin North Am. 2023 Jun;50(2):349-361.doi: 10.1016/j.ogc.2023.02.007. Epub 2023 Apr 4.

David M Higgins 1, Sean T O'Leary 2
 
8.New perspectives on development of curative strategies for chronic hepatitis B
 

Clin Gastroenterol Hepatol. 2023 Apr 18;S1542-3565(23)00279-3.doi: 10.1016/j.cgh.2023.02.032. Online ahead of print.

Jordan J Feld 1, Anna S Lok 2, Fabien Zoulim 3
 
9.Hepatitis B and C in individuals with a history of antipsychotic medication use: A population-based evaluation
 

PLoS One. 2023 Apr 14;18(4):e0284323. doi: 10.1371/journal.pone.0284323. eCollection 2023.

Amnah Awan 1, Sharara Shakik 1, Hailey R Banack 1, David N Fisman 1, Alison E Simmons 1
 
10.Hepatitis B immune status of staff in smaller acute healthcare facilities
 

Aust Health Rev. 2023 Apr;47(2):254-257. doi: 10.1071/AH22219.

Alex Hoskins 1, Leon James Worth 2, Michael James Malloy 1, Katherine Walker 1, Ann Bull 1, Noleen Bennett 3
 
11.Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
 

United European Gastroenterol J. 2023 Apr;11(3):293-304. doi: 10.1002/ueg2.12376.Epub 2023 Mar 25.

Mathias Jachs 1, Raphael Sauberer 1, Alexander Stiegler 1, Anton Dechêne 1, Raphael Tazreiter 1, Lukas Hartl 1, David Bauer 1, Lorenz Balcar 1, Robert Strassl 2, Mattias Mandorfer 1, Michael Trauner 1, Petra Munda 1, Peter Ferenci 1, Thomas Reiberger 1
 
12.A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
 

J Hepatol. 2023 May;78(5):926-936.doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28.

Florian van Bömmel 1, Kerstin Stein 2, Renate Heyne 3, Jörg Petersen 4, Peter Buggisch 4, Christoph Berg 5, Stefan Zeuzem 6, Andreas Stallmach 7, Martin Sprinzl 8, Eckart Schott 9, Anita Pathil-Warth 10, Ulrike von Arnim 11, Verena Keitel 12, Jürgen Lohmeyer 13, Karl-Georg Simon 14, Christian Trautwein 15, Andreas Trein 16, Dietrich Hüppe 17, Markus Cornberg 18, Frank Lammert 19, Patrick Ingiliz 20, Reinhart Zachoval 21, Holger Hinrichsen 22, Alexander Zipprich 23, Hartmuth Klinker 24, Julian Schulze Zur Wiesch 25, Anett Schmiedeknecht 26, Oana Brosteanu 26, Thomas Berg 27
 
13.Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States
 

J Viral Hepat. 2023 Feb 26. doi: 10.1111/jvh.13823. Online ahead of print.

Robert J Wong 1 2, Loralee Rupp 3, Mei Lu 4, Zeyuan Yang 2, Yihe G Daida 5, Mark Schmidt 6, Joseph A Boscarino 7, Stuart C Gordon 8, Amit S Chitnis 9
 
14.Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023
 

MMWR Recomm Rep. 2023 Mar 10;72(1):1-25. doi: 10.15585/mmwr.rr7201a1.

Erin E Conners 1, Lakshmi Panagiotakopoulos 1, Megan G Hofmeister 1, Philip R Spradling 1, Liesl M Hagan 1, Aaron M Harris 1, Jessica S Rogers-Brown 1, Carolyn Wester 1, Noele P Nelson 1; Contributors
 
15.Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States
 

Front Med (Lausanne). 2023 Mar 2;10:1070420. doi: 10.3389/fmed.2023.1070420.eCollection 2023.

Ilona Argirion 1, Parag Mahale 1, Ruth M Pfeiffer 2, Ping Liu 3, Adaora A Adimora 4, Matthew J Akiyama 5 6, Hector H Bolivar 7, Audrey French 8 9, Michael Plankey 10, Jennifer C Price 11, Aadia Rana 12, Anandi Sheth 13 14, Jill Koshiol 1, Eric C Seaberg 15, Mark H Kuniholm 16, Jeffrey Glenn 3, Thomas R O'Brien 1
 
16.Chronic hepatitis B and HIV coinfection
 

Top Antivir Med. 2023 Mar 31;31(1):14-22.

Maria A Corcorran 1, Nina Kim 1
 
17.What will it take to cure hepatitis B?
 

Hepatol Commun. 2023 Mar 24;7(4):e0084. doi: 10.1097/HC9.0000000000000084.eCollection 2023 Apr 1.

Wen-Juei Jeng 1 2, Anna S F Lok 3
 
18.Missed opportunities for diagnosis of hepatitis B and C in individuals diagnosed with decompensated cirrhosis or hepatocellular carcinoma
 

J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16162. Online ahead of print.

George Mnatzaganian 1 2, Jennifer H MacLachlan 1 3, Nicole Allard 1 3, Chelsea Brown 1, Stacey Rowe 4 5, Benjamin C Cowie 1 3 6
 
19. Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial
 

Sex Transm Infect. 2023 Mar;99(2):140-142.doi: 10.1136/sextrans-2022-055634. Epub 2022 Dec 8.

Paul Le Turnier 1 2 3, Isabelle Charreau 4, Audrey Gabassi 5 6, Diane Carette 4, Laurent Cotte 7, Gilles Pialoux 8, Cécile Tremblay 9, Bruno Spire 10, Marie-Laure Chaix 5 6, Laurence Meyer 4 11, Catherine Capitant 4, Constance Delaugerre 5 6, François Raffi # 12 2, Jean-Michel Molina # 6 13; ANRS IPERGAY study group
 
20. Chronic Hepatitis B Virus: What an Internist Needs to Know: Serologic Diagnosis, Treatment Options, and Hepatitis B Virus Reactivation
 

Med Clin North Am. 2023 May;107(3):435-447. doi: 10.1016/j.mcna.2022.12.002.Epub 2023 Feb 20.

Peter D Block 1, Joseph K Lim 2
 
21.Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019
 

Med Care. 2023 Apr 1;61(4):247-253. doi: 10.1097/MLR.0000000000001825. Epub 2023 Feb 3.

Thi T Hang Pham 1, Mehlika Toy 1, David Hutton 2, William Thompson 3, Erin E Conners 3, Noele P Nelson 3, Joshua A Salomon 4, Samuel So 1
 
22.Prevalence of anti-hepatitis B core in men who have sex with men attending a sexual health clinic in Brighton, UK, from 2012 to 2019
 

Sex Health. 2023 Feb;20(1):92-95. doi: 10.1071/SH22120.

Mahmoud Gouda 1, Colin Fitzpatrick 1, Deborah Williams 1, Daniel Richardson 2
 
23.Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
 

Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006.Epub 2023 Feb 13.

Giuseppina Brancaccio 1, Barbara Coco 2, Alessandra Nardi 3, Maria Giovanna Quaranta 4, Maria Elena Tosti 4, Luigina Ferrigno 4, Irene Cacciola 5, Vincenzo Messina 6, Luchino Chessa 7, Filomena Morisco 8, Michele Milella 9, Francesco Barbaro 10, Alessia Ciancio 11, Francesco Paolo Russo 12, Nicola Coppola 13, Pierluigi Blanc 14, Ernesto Claar 15, Gabriella Verucchi 16, Massimo Puoti 17, Anna Linda Zignego 18, Liliana Chemello 19, Salvatore Madonia 20, Stefano Fagiuoli 21, Alfredo Marzano 22, Carlo Ferrari 23, Pietro Lampertico 24, Vito Di Marco 25, Antonio Craxì 26, Teresa Antonia Santantonio 27, Giovanni Raimondo 5, Maurizia R Brunetto 2, Giovanni Battista Gaeta 28, Loreta A Kondili 29; PITER collaborating investigators
 
24.Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature
 

Front Oncol. 2023 Feb 7;13:1095780. doi: 10.3389/fonc.2023.1095780.eCollection 2023.

Cesare Mazzaro 1, Riccardo Bomben 1, Marcella Visentini 2, Laura Gragnani 3, Luca Quartuccio 4, Francesco Saccardo 5, Marco Sebastiani 6, Davide Filippini 7, Gianfranco Lauletta 8, Giuseppe Monti 5, Valter Gattei 1
 
25.Evolving considerations for choice of hepatitis B vaccine
 

Am J Manag Care. 2023 Feb;29(1 Suppl):S3-S14. doi: 10.37765/ajmc.2023.89325.

Dalga D Surofchy 1, Neil Shieh, Iris Tam
 
26.Hepatitis B
 

Lancet. 2023 Feb 9;S0140-6736(22)01468-4.doi: 10.1016/S0140-6736(22)01468-4. Online ahead of print.

Wen-Juei Jeng 1, George V Papatheodoridis 2, Anna S F Lok 3
 
27.Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance
 

Viruses. 2023 Feb 1;15(2):409. doi: 10.3390/v15020409.

Sheila F O'Brien 1 2, Cassandra N Reedman 1 3, Carla Osiowy 4 5 6, Shelly Bolotin 7 8 9 10, Qi-Long Yi 1 2, Lillian Lourenço 3, Antoine Lewin 11 12, Mawuena Binka 13 14, Niamh Caffrey 1, Steven J Drews 15 16
 
28.Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis
 

Drug Alcohol Rev. 2023 Jan 4. doi: 10.1111/dar.13595. Online ahead of print.

Anjalee Syangbo 1, Matthew Hickman 1, Samantha Colledge-Frisby 2 3, Janni Leung 2 4, Jason Grebely 5, Sarah Larney 2 6 7, Louisa Degenhardt 2, Adam Trickey 1
 
29.Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
 

Gut. 2023 Jan 25;gutjnl-2022-328041. doi: 10.1136/gutjnl-2022-328041. Online ahead of print.

Harry L A Janssen 1 2, Jinlin Hou 3, Tarik Asselah 4, Henry L Y Chan 5, Fabien Zoulim 6, Yasuhito Tanaka 7, Ewa Janczewska 8, Ronald G Nahass 9, Stefan Bourgeois 10, Maria Buti 11, Pietro Lampertico 12 13, Oliver Lenz 14, Thierry Verbinnen 14, Joris Vandenbossche 14, Willem Talloen 14, Ronald Kalmeijer 15, Maria Beumont 15, Michael Biermer 16, Umesh Shukla 15
 
30.Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020
 

Eur J Intern Med. 2023 Jan;107:86-92. doi: 10.1016/j.ejim.2022.11.012. Epub 2022 Nov 14.

D P C van der Spek 1, W K Katwaroe 2, L A van Kleef 2, S Brakenhoff 2, R A de Man 2, R J de Knegt 2, A J van der Meer 2, M J Sonneveld 2
 
31.Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B
 

Dig Dis. 2023;41(1):115-123. doi: 10.1159/000526933. Epub 2022 Sep 7.

Daniel Q Huang 1 2, Dong Hyun Lee 3 4, Michael H Le 4, An Le 4, Yee Hui Yeo 4, Huy N Trinh 5, Mimi Chung 6, Vy Nguyen 4, Tiffani Johnson 7, Jian Q Zhang 8, Clifford Wong 9, Christopher Wong 9, Jiayi Li 10, Ramsey Cheung 4 11, Mindie H Nguyen 4
 
32.Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
 

Gut. 2023 Jan 27;gutjnl-2022-328380. doi: 10.1136/gutjnl-2022-328380. Online ahead of print.

Lena Allweiss 1 2, Barbara Testoni 3 4, Mei Yu 5, Julie Lucifora 3 4 6, Chunkyu Ko 7 8, Bingqian Qu 9 10, Marc Lütgehetmann 2 11, Haitao Guo 12 13, Stephan Urban 2 9, Simon P Fletcher 5, Ulrike Protzer 2 7, Massimo Levrero 3 4, Fabien Zoulim 14 4, Maura Dandri 15 2
 
33.Management of Hepatitis B and C during Pregnancy: Neonatal Implications
 

Neoreviews. 2023 Jan 1;24(1):24-30. doi: 10.1542/neo.24-1-e24.

Katherine Pressman 1, Stephanie Ros 1
 
34.Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease
 

Inflamm Bowel Dis. 2022 Jul 2;izac129. doi: 10.1093/ibd/izac129. Online ahead of print.

Fang Xu 1, Neal deJong 2, Michael D Kappelman 2, Kurt J Greenlund 1, Susan A Carlson 1
 
35.6- and 12-Month Outcomes after 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease
 

J Pediatr Gastroenterol Nutr. 2022 Jul 1;75(1):70-75. doi: 10.1097/MPG.0000000000003475.Epub 2022 May 27.

Nicole Davidson 1, Jessica Rutsky 2, Josh B Bricker 3, Jennifer Smith 4, Ross M Maltz 1, Jennifer L Dotson 5, Hilary K Michel 6, Brendan Boyle 6
 
36.Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes
 

Diabetologia. 2022 Jul;65(7):1108-1118. doi: 10.1007/s00125-022-05701-w. Epub 2022 Apr 30.

Clemens Kamrath 1, Sascha R Tittel 2 3, Desiree Dunstheimer 4, Elke Fröhlich-Reiterer 5, Markus Freff 6, Claudia Böttcher 7, Nadine Scheffler 8, Stefanie Lenze 9, Elke Gericke 10, Susanne Thiele 11, Reinhard W Holl 2 3
 
37.Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study
 

Front Oncol. 2023 Jan 24;13:1044098. doi: 10.3389/fonc.2023.1044098. eCollection 2023.

Angioletta Lasagna 1, Giuseppe Albi 2, Renato Maserati 2, Andrea Zuccarini 1, Mattia Quaccini 1, Fausto Baldanti 3 4, Paolo Sacchi 2, Raffaele Bruno 2 4, Paolo Pedrazzoli 1 5
 
38.The scientific basis of combination therapy for chronic hepatitis B functional cure
 

Nat Rev Gastroenterol Hepatol. 2023 Jan 11. doi: 10.1038/s41575-022-00724-5.Online ahead of print.

Seng Gee Lim 1, Thomas F Baumert 2, Carolina Boni 3, Ed Gane 4, Massimo Levrero 5, Anna S Lok 6, Mala K Maini 7, Norah A Terrault 8, Fabien Zoulim 9
 
39.Impact of pharmacist motivational interviewing on hepatitis B vaccination in adults with diabetes
 

J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):66-73.e1.doi: 10.1016/j.japh.2022.08.013. Epub 2022 Aug 19.

Lucas A Berenbrok, Chiara Gessler, Levent Kirisci, Oscar Herrera-Restrepo, Kim C Coley
 
40.Therapies against chronic hepatitis B infections: The times they are a-changin', but the changing is slow!
 

Antiviral Res. 2023 Feb;210:105515. doi: 10.1016/j.antiviral.2022.105515.Epub 2023 Jan 2.

David Durantel 1
 
41.Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways
 

J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375.

Samuel A L Hall 1 2, Gareth S Burns 1 2, Benjamin J Mooney 2, Rosemary Millen 2, Rachel Morris 2, Sara Vogrin 2, Vijaya Sundararajan 3, Dilip Ratnam 4, Miriam T Levy 5, John S Lubel 6 7, Amanda J Nicoll 8, Simone I Strasser 9 10, William Sievert 4 11, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, Scott Bowden 17, Stephen A Locarnini 17, Alexander J Thompson 1 2, Kumar Visvanathan 1 2
 
42.Hepatitis B and C in Pregnancy and Children: A Canadian Perspective
 

Viruses. 2022 Dec 29;15(1):91. doi: 10.3390/v15010091.

Andrew B Mendlowitz 1, Jordan J Feld 1, Mia J Biondi 1 2
 
43.How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review
 

Clin Interv Aging. 2022 Dec 9;17:1811-1820. doi: 10.2147/CIA.S366255.eCollection 2022.

Chan Keat Kang 1, Paul N Brennan 1, John F Dillon 1
 
44.Liver Damage and microRNAs: An Update
 

Curr Issues Mol Biol. 2022 Dec 23;45(1):78-91. doi: 10.3390/cimb45010006.

Erika Cione 1 2, Diana Marisol Abrego Guandique 2 3, Maria Cristina Caroleo 2 3, Filippo Luciani 4, Manuela Colosimo 5, Roberto Cannataro 1 2
 
45.A Systematic Review on Current Trends in the Treatment of Chronic Hepatitis B to Predict Disease Remission and Relapse
 

Cureus. 2022 Dec 6;14(12):e32247. doi: 10.7759/cureus.32247.eCollection 2022 Dec.

Samia Rauf R Butt 1, Travis Satnarine 2, Pranuthi Ratna 1, Aditi Sarker 1, Adarsh Srinivas Ramesh 3, Carlos Munoz 3, Dawood Jamil 3, Hadrian Hoang-Vu Tran 3, Mafaz Mansoor 1, Safeera Khan 3
 
46.Hepatitis B virus movement through the hepatocyte: An update
 

Biol Cell. 2022 Dec;114(12):325-348. doi: 10.1111/boc.202200060.Epub 2022 Aug 30.

Reinhild Prange 1
 
47.Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus
 

Int J Mol Sci. 2022 Dec 15;23(24):15973. doi: 10.3390/ijms232415973.

Daniel G Sausen 1, Oren Shechter 1, William Bietsch 2, Zhenzhen Shi 2, Samantha M Miller 3, Elisa S Gallo 4, Harel Dahari 2, Ronen Borenstein 2
 
48.Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection
 

Antimicrob Agents Chemother. 2022 Dec 15;e0134822. doi: 10.1128/aac.01348-22.Online ahead of print.

Dara Burdette 1, Anastasia Hyrina 1, Zhijuan Song 1, Rudolf K Beran 1, Tara Cheung 1, Sarah Gilmore 1, Tetsuya Kobayashi 1, Li Li 1, Yang Liu 1, Anita Niedziela-Majka 1, Jonathan Medley 1, Upasana Mehra 1, Philip Morganelli 1, Nikolai Novikov 1, Congrong Niu 1, Danny Tam 1, Jennifer Tang 1, Jianhong Wang 1, Qin Yue 1, Simon P Fletcher 1, Meghan M Holdorf 1, William E Delaney 4th 1, Becket Feierbach 1, Scott Lazerwith 1
 
49.Assessment of the cobas® HBV RNA investigational assay in the setting of nucleoside analog therapy cessation
 

Med Virol. 2022 Dec;94(12):6116-6121. doi: 10.1002/jmv.28078. Epub 2022 Aug 30.

Kathy Jackson 1, Sara Bonanzinga 1, Ros Edwards 1, Kumar Visvanathan 2, Xin Li 1, Samuel Hall 3, Alison Kuchta 4, Jesse A Canchola 4, Alex J Thompson 3
 
50.Logics of control and self-management in narratives of people living with HIV, hepatitis C and hepatitis B
 

Cult Health Sex. 2022 Dec 7;1-16. doi: 10.1080/13691058.2022.2149858. Online ahead of print.

Joanne Bryant 1, Anthony K J Smith 1, Asha Persson 1, Kylie Valentine 2, Kerryn Drysdale 1, Jack Wallace 3, Myra Hamilton 4, Christy E Newman 1
 
51.State-of-the-art and emerging antivirals for chronic hepatitis B infection
 

Expert Opin Pharmacother. 2022 Dec;23(18):1999-2012.doi: 10.1080/14656566.2022.2144219. Epub 2022 Nov 22.

Margarita Papatheodoridi 1, George V Papatheodoridis 1
 
52.EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B
 

Antivir Ther. 2022 Dec;27(6):13596535221127848. doi: 10.1177/13596535221127848.

Jordan J Feld 1, Eric Lawitz 2, Tuan Nguyen 3, Jacob Lalezari 4, Tarek Hassanein 5, Paul Martin 6, Steven-Huy Han 7, Douglas Dieterich 8, Jeanne-Marie Giard 9, Guy De La Rosa 10, Alaa Ahmad 10, Ed Luo 10, Annie L Conery 10, Nathalie Adda 10
 
53.The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile
 

Int J Environ Res Public Health. 2022 Dec 6;19(23):16365. doi: 10.3390/ijerph192316365.

Sara Boccalini 1, Benedetta Bonito 1, Beatrice Zanella 1, Davide Liedl 2, Paolo Bonanni 1, Angela Bechini 1
 
54.Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
 

Aliment Pharmacol Ther. 2022 Nov 25. doi: 10.1111/apt.17299. Online ahead of print.

Josef Wagner 1 2, Lilly Yuen 1 3, Margaret Littlejohn 1, Vitina Sozzi 1, Kathy Jackson 1, Ross Martin 4, Thomas Aeschbacher 4, Vithika Suri 4, Susanna K Tan 4, Becket Feierbach 4, Anuj Gaggar 4, Patrick Marcellin 5, Maria Buti Ferret 6, Harry L A Janssen 7, Ed Gane 8, Niamh Meagher 3, David J Price 3 9, Darren Wong 1 10, Alexander T Thompson 10, Peter A Revill 1 3 11
 
55.Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country
 

Eur J Intern Med. 2022 Nov 30;S0953-6205(22)00415-0. doi: 10.1016/j.ejim.2022.11.024.Online ahead of print.

Sylvia M Brakenhoff 1, Roos Hoekstra 2, Pieter Honkoop 3, Robert Roomer 4, Jan G den Hollander 5, Geert Bezemer 6, Robert J de Knegt 2, Milan J Sonneveld 2, Robert A de Man 2
 
56.Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom
 

Cost Eff Resour Alloc. 2022 Nov 14;20(1):60. doi: 10.1186/s12962-022-00388-7.

Jack Williams 1 2, Peter Vickerman 3 4, Elizabeth Smout 5, Emma E Page 6, Khine Phyu 6, Mark Aldersley 6, Gaia Nebbia 7, Sam Douthwaite 7, Laura Hunter 8, Murad Ruf 9, Alec Miners 10 11
 
57.Long-Acting Treatments for Hepatitis B
 

Clin Infect Dis. 2022 Nov 21;75(Supplement_4):S517-S524. doi: 10.1093/cid/ciac718.

David L Thomas 1, Jennifer J Kiser 2, Marc M Baum 3
 
58.New hepatitis B drug development disillusions: time to reset?
 

Lancet Gastroenterol Hepatol. 2022 Nov 4;S2468-1253(22)00341-7.doi: 10.1016/S2468-1253(22)00341-7. Online ahead of print.

Jean-Michel Pawlotsky 1
 
59.Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
 

N Engl J Med. 2022 Nov 24;387(21):1957-1968. doi: 10.1056/NEJMoa2210027.Epub 2022 Nov 8.

Man-Fung Yuen 1, Seng-Gee Lim 1, Robert Plesniak 1, Keiji Tsuji 1, Harry L A Janssen 1, Cristina Pojoga 1, Adrian Gadano 1, Corneliu P Popescu 1, Tatyana Stepanova 1, Tarik Asselah 1, Gheorghe Diaconescu 1, Hyung Joon Yim 1, Jeong Heo 1, Ewa Janczewska 1, Alexander Wong 1, Nevin Idriz 1, Michio Imamura 1, Giuliano Rizzardini 1, Koichi Takaguchi 1, Pietro Andreone 1, Manuela Arbune 1, Jinlin Hou 1, Sung Jae Park 1, Andrei Vata 1, Jennifer Cremer 1, Robert Elston 1, Tamara Lukic 1, Geoff Quinn 1, Lauren Maynard 1, Stuart Kendrick 1, Helene Plein 1, Fiona Campbell 1, Melanie Paff 1, Dickens Theodore 1, B-Clear Study Group
 
60.Prevalence of hepatitis B virus amongst refugees, asylum seekers and internally displaced persons in low- and middle-income countries: A systematic review
 

J Viral Hepat. 2022 Nov 10. doi: 10.1111/jvh.13770. Online ahead of print.

Caroline Lee 1 2, Theophilus I Emeto 1 3 4, Nick Walsh 5
 
61.Chronic Hepatitis B Virus and Hepatitis D Virus: New Developments
 

Clin Liver Dis. 2023 Feb;27(1):17-25. doi: 10.1016/j.cld.2022.08.001.Epub 2022 Oct 18.

Ann Robinson 1, Robert Wong 2, Robert G Gish 3
 
62.Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis
 

J Viral Hepat. 2022 Dec;29(12):1107-1114. doi: 10.1111/jvh.13751.Epub 2022 Oct 14.

Christina Chou 1, Nicolette Veracruz 2, Amit S Chitnis 3, Robert J Wong 4 5
 
63.Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial
 

J Gen Intern Med. 2022 Oct;37(13):3242-3250.doi: 10.1007/s11606-021-07232-3. Epub 2022 Jan 6.

Mandana Khalili 1, Nicole J Kim 2, Janice Y Tsoh 3, Judith M E Walsh 4, L Elizabeth Goldman 4, Ginny Gildengorin 4, Ching Wong 4, Mi T Tran 4, Edgar Yu 3, Michael Thanh Sharp 4, Vivian H LeTran 4, Vi-Van Nguyen 4, Tung T Nguyen 4
 
64.Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus
 

Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101773.doi: 10.1016/j.clinre.2021.101773. Epub 2021 Jul 28.

Vincent Leroy 1, Stéphane Chevaliez 2, Marie Decraecker 3, Dominique Roulot 4, Jean Nana 5, Tarik Asselah 6, Xavier Causse 7, David Durantel 8, Vincent Thibaut 9, Nathalie Ganne-Carrié 4, Christophe Bureau 10, Victor de Lédinghen 3, Marc Bourlière 11
 
65.The value of active follow up of a newly acquired hepatitis B infection - lessons for current approaches
 

Commun Dis Intell (2018). 2022 Oct 20;46. doi: 10.33321/cdi.2022.46.71.

Adam G Capon 1 2, Anthea L Katelaris 1, Eleanor Sullivan 1, Nicolas Gonzalez 1, Alice Zhu 1, Maria Browne 1, Milica Mihajlovic 1, Mark J Ferson 1 3, Vicky Sheppeard 1 2
 
66.Feasibility of hepatitis B elimination in high-income countries with ongoing immigration
 

J Hepatol. 2022 Oct;77(4):947-956. doi: 10.1016/j.jhep.2022.04.014. Epub 2022 Apr 26.

Feng Tian 1, Jordan J Feld 2, Zeny Feng 3, Beate Sander 4, William W L Wong 5
 
67.Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
 

Hum Vaccin Immunother. 2022 Oct 21;2136912. doi: 10.1080/21645515.2022.2136912.Online ahead of print.

Matthias Girndt 1, Manfred Plüer 2, Frank Dellanna 3, Ann K Michelsen 4, Joachim Beige 5, Kai Toussaint 6, Hubert J Wehweck 7, Michael Koch 8, Syrus Hafezi Rachti 9, Justus Faust 10, Hans-Peter Bosselmann 11, Oliver Witzke 12, Robert S Janssen 13, HBV-18 Study Investigators 14
 
68.Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B
 

Viruses. 2022 Oct 11;14(10):2229. doi: 10.3390/v14102229.

Warshan K Katwaroe 1, Sylvia M Brakenhoff 1, Daniël P C van der Spek 1, Robert J de Knegt 1, Laurens A van Kleef 1, Robert A de Man 1, Adriaan J P van der Meer 1, Milan J Sonneveld 1, The Icarus Study Group 1
 
69.Evaluating the cost-effectiveness of hepatitis B vaccination strategies in high-impact settings for adults
 

J Viral Hepat. 2022 Oct 6. doi: 10.1111/jvh.13759. Online ahead of print.

Eric W Hall 1, Prabhu Gounder 2, John Angles 3, Noele P Nelson 4, Eli S Rosenberg 3 5, Mark K Weng 4
 
70.Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers' attitudes and practices
 

Hum Vaccin Immunother. 2022 Oct 26;2123180. doi: 10.1080/21645515.2022.2123180.Online ahead of print.

Oscar Herrera-Restrepo 1, Kimberly Davis 2, Carolyn Sweeney 2, Eric Davenport 3, Parinaz Ghaswalla 1, Philip O Buck 1
 
71.Current Best Practice in Hepatitis B Management & Understanding Long-Term Prospects for Cure
 

Gastroenterology. 2022 Oct 12;S0016-5085(22)01166-0.doi: 10.1053/j.gastro.2022.10.008. Online ahead of print.

David Yardeni 1, Kyong-Mi Chang 2, Marc G Ghany 3
 
72.Linkage-to-Care Following Community-Based HBV and HCV Screening Among Immigrants from the Washington-Baltimore Metropolitan Area, 2016-2019
 

J Immigr Minor Health. 2022 Oct;24(5):1137-1144. doi: 10.1007/s10903-022-01327-7.Epub 2022 Jan 22.

Daisy Le 1 2, Annie Coriolan Ciceron 3, Jane Pan 4, Hee-Soon Juon 5, Carla J Berg 6, T Angeline Nguyen 4, Hai Chi Le 4, Y Tony Yang 3 6
 
73.Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
 

Lancet Infect Dis. 2022 Sep 13;S1473-3099(22)00318-8. doi: 10.1016/S1473-3099(22)00318-8.Online ahead of print.

Heiner Wedemeyer 1, Katrin Schöneweis 2, Pavel Bogomolov 3, Antje Blank 4, Natalia Voronkova 5, Tatiana Stepanova 6, Olga Sagalova 7, Vladimir Chulanov 8, Marina Osipenko 9, Viacheslav Morozov 10, Natalia Geyvandova 11, Snezhana Sleptsova 12, Igor G Bakulin 13, Ilsiyar Khaertynova 14, Marina Rusanova 15, Anita Pathil 16, Uta Merle 17, Birgit Bremer 18, Lena Allweiss 19, Florian A Lempp 20, Kerstin Port 18, Mathias Haag 21, Matthias Schwab 22, Julian Schulze Zur Wiesch 19, Markus Cornberg 18, Walter E Haefeli 4, Maura Dandri 19, Alexander Alexandrov 23, Stephan Urban 24
 
74.Can statins lessen the burden of virus mediated cancers?
 

Infect Agent Cancer. 2022 Sep 4;17(1):47. doi: 10.1186/s13027-022-00460-0.

Eva H Clark 1 2 3, Sarah T Ahmed 4 5, Elaine Chang 4 5, Elizabeth Y Chiao 6, Donna L White 4 5 7
 
75. Fitting Health Care to People: Understanding and Adapting to the Epidemiology and Health Literacy of People Affected by Viral Hepatitis from Culturally and Linguistically Diverse Migrant Backgrounds
 

J Immigr Minor Health. 2022 Oct;24(5):1196-1205. doi: 10.1007/s10903-021-01305-5.Epub 2021 Nov 17.

Belaynew W Taye 1 2 3, Patricia C Valery 4, Burglind Liddle 5, Aidan J Woodward 6, Donata Sackey 7, Suzanne Williams 8, Gary K F Chang 9, Paul J Clark 10 11 4 5
 
76. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure
 

Front Microbiol. 2022 Sep 2;13:972687. doi: 10.3389/fmicb.2022.972687.eCollection 2022.

Romina Salpini 1, Stefano D'Anna 1, Livia Benedetti 1, Lorenzo Piermatteo 1, Upkar Gill 2, Valentina Svicher 3, Patrick T F Kennedy 2
 
77.Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark
 

J Viral Hepat. 2022 Sep;29(9):727-736. doi: 10.1111/jvh.13713. Epub 2022 Jun 9.

Signe Bollerup 1, Sofie Hallager 1, Frederik Engsig 1, Amanda Mocroft 2 3, Henrik Krarup 4 5, Lone G Madsen 6 7, Peter Thielsen 8, Ulla Balslev 9, Helene Mens 10, Toke S Barfod 11, Mette R Clausen 12, Lise Hobolth 13, Alex L Laursen 14, Britta Tarp 15, Birgit T Roege 16, Jesper B Hansen 5, Lone Mygind 17, Peer B Christensen 18 19, Jan Gerstoft 7 20, Nina Weis 1 7
 
78.Acute Hepatitis B Virus Infection in North American Adults
 

Clin Gastroenterol Hepatol. 2022 Sep 15;S1542-3565(22)00876-X.doi: 10.1016/j.cgh.2022.09.004. Online ahead of print.

Richard K Sterling 1, Abdus S Wahed 2, Gavin Cloherty 3, Jay H Hoofnagle 4, William M Lee 5, Hepatitis B Research Network Investigators
 
79.Management of Chronic Hepatitis B in HIV-Coinfected Patients
 

Viruses. 2022 Sep 13;14(9):2022. doi: 10.3390/v14092022.

Massimo Fasano 1, Maria Cristina Poliseno 2, Josè Ramon Fiore 2, Sergio Lo Caputo 2, Antonella D'Arminio Monforte 3, Teresa Antonia Santantonio 2
 
80.Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines
 

J Gen Intern Med. 2022 Sep 22. doi: 10.1007/s11606-022-07806-9.Online ahead of print.

Samuel Etienne 1, Jürg Vosbeck 2, Christine Bernsmeier 3, Michael Osthoff 4 5
 
81.A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection
 

J Med Virol. 2022 Aug 31. doi: 10.1002/jmv.28105. Online ahead of print.

Angie S Price 1, Amy K Nelson 1, Alip Ghosh 1, Shyamasundaran Kottilil 1, Joel V Chua 1
 
82.Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
 

Clin Epidemiol. 2022 Jul 18;14:879-888. doi: 10.2147/CLEP.S361910. eCollection 2022.

Frederik Faergemann Lau 1, Signe Bollerup 1, Frederik Engsig 1, Henrik Krarup 2, Lone Hagens Mygind 3, Jesper Bach Hansen 3, Lone Galmstrup Madsen 4 5, Peter Thielsen 6, Ulla Balslev 7, Lars Nørregaard Nielsen 8, Toke S Barfod 9, Mette Rye Clausen 10, Lise Hobolth 11, Alex Lund Laursen 12, Britta Tarp 13, Birgit T Roege 14, Jan Gerstoft 15, Peer Brehm Christensen 16 17, Nina Weis 1 5
 
83.Antibody response to an accelerated course of Hepatitis B vaccination
 

Occup Med (Lond). 2022 Aug 6;kqac054. doi: 10.1093/occmed/kqac054. Online ahead of print.

P C S Lian 1, B Morrish 2
 
84.Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
 

Am J Gastroenterol. 2022 Sep 1;117(9):1454-1461. doi: 10.14309/ajg.0000000000001879.Epub 2022 Jun 24.

Hamish Innes 1 2 3, Victoria Hamill 1 2, Scott A McDonald 1 2, Peter C Hayes 4, Philip Johnson 5, John F Dillon 6, Jen Bishop 2, Alan Yeung 1 2, April Went 2, 
 
85.Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis
 

Gut. 2022 Aug;71(8):1629-1641. doi: 10.1136/gutjnl-2020-323979.Epub 2021 Sep 7.

Samuel Anthony Lachlan Hall 1, Sara Vogrin 2, Olivia Wawryk 2, Gareth S Burns 3, Kumar Visvanathan 2 4, Vijaya Sundararajan 5, Alexander Thompson 3 2
 
86.Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis
 

Inflamm Bowel Dis. 2022 Sep 1;28(9):1430-1442. doi: 10.1093/ibd/izab266.

Athanasios Desalermos 1, Michael Pimienta 2, Markos Kalligeros 3, Fadi Shehadeh 3, Leonidas Diamantopoulos 4, George Karamanolis 5, Freddy Caldera 6, Francis A Farraye 7
 
87.Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis
 

Lancet Gastroenterol Hepatol. 2022 Oct;7(10):932-942.doi: 10.1016/S2468-1253(22)00201-1. Epub 2022 Aug 10.

Yu Ri Im 1, Rukmini Jagdish 2, Damien Leith 3, Jin Un Kim 4, Kyoko Yoshida 5, Amir Majid 6, Yueqi Ge 7, Gibril Ndow 8, Yusuke Shimakawa 9, Maud Lemoine 10
 
88.Meta-analysis: hepatitis B reactivation in patients receiving biological therapy
 

Aliment Pharmacol Ther. 2022 Oct;56(7):1104-1118. doi: 10.1111/apt.17155.Epub 2022 Aug 17.

Hydar El Jamaly 1 2, Guy D Eslick 3, Martin Weltman 1 2
 
89.Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States
 

J Public Health Manag Pract. 2022 Sep-Oct;28(5):452-462.doi: 10.1097/PHH.0000000000001536.

Robert J Wong 1, Harvey W Kaufman, Justin K Niles, William A Meyer 3rd, Amit S Chitnis
 
90.Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis
 

J Clin Gastroenterol. 2022 Aug 1;56(7):601-617.doi: 10.1097/MCG.0000000000001533. Epub 2021 Apr 8.

Robert J Wong 1 2, Ashley Hubbard 3, Laurie Bagley 4, Rita Shiau 5, Amit S Chitnis 6
 
91.Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care
 

Liver Int. 2022 Sep 1. doi: 10.1111/liv.15414. Online ahead of print.

Rachael Jacob 1 2, David S Prince 1 2, Joseph L Pipicella 1 3, Angela Nguyen 1 4, Melissa Bagatella 1, Frank Alvaro 1 5, Michael Maley 1 3 5, Hong Foo 1 5, Paul Middleton 1 2 6, Tahrima Kayes 1, Julia DiGirolamo 1, Scott A Davison 1 2, Miriam T Levy 1 2 3
 
92.HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
 

Viruses. 2022 Jul 30;14(8):1691. doi: 10.3390/v14081691.

Ferruccio Bonino 1, Piero Colombatto 2, Maurizia R Brunetto 1 2
 
93.Hepatitis B and C in Children
 

Clin Liver Dis. 2022 Aug;26(3):403-420. doi: 10.1016/j.cld.2022.03.005.Epub 2022 Jun 25.

A Bailey Sperry 1, Aaron Bennett 2, Jessica Wen 3
 
94.Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
 

Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829. doi: 10.1016/S2468-1253(22)00124-8.Epub 2022 Jun 21.

GBD 2019 Hepatitis B Collaborators
 
95.Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
 

Clin Gastroenterol Hepatol. 2022 Aug;20(8):1766-1775. doi: 10.1016/j.cgh.2021.07.036.Epub 2021 Jul 27.

Paul Martin 1, Mindie H Nguyen 2, Douglas T Dieterich 3, Daryl T-Y Lau 4, Harry L A Janssen 5, Marion G Peters 6, Ira M Jacobson 7
 
96.Hepatitis B and Acute Liver Failure
 

Crit Care Nurs Clin North Am. 2022 Sep;34(3):259-265.doi: 10.1016/j.cnc.2022.04.012. Epub 2022 Jul 20.
 
97.Elucidating a Silent Illness: Hepatitis B Knowledge Among Asian Individuals in an Urban Center
 

J Public Health Manag Pract. 2022 Jul-Aug;28(4):417-424.doi: 10.1097/PHH.0000000000001513. Epub 2022 Apr 5.

Heidi J Stahl 1, Anna K Wu, Henry Li, David Hu, Wei Liu, Suet Kam Lam
 
98.The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
 

HIV Med. 2022 Jul;23(6):585-598. doi: 10.1111/hiv.13210. Epub 2021 Dec 9.

Amanda Mocroft 1 2, Jose M Miro 3, Gilles Wandeler 4, Josep M Llibre 5, Anders Boyd 6 7, Kathrin van Bremen 8, Marek Beniowski 9, Julia Mikhalik 10, Matthias Cavassini 11, Fernando Maltez 12, Claudine Duvivier 13 14 15 16, Caterina Uberti Foppa 17, Brygida Knysz 18, Elzbieta Bakowska 19, Elena Kuzovatova 20, Pere Domingo 21, Alexandra Zagalo 22, Jean-Paul Viard 23, Olaf Degen 24, Ana Milinkovic 25, Thomas Benfield 26, Lars Peters 1, EuroSIDA study group
 
99.Improving Care for Patients with Chronic Hepatitis B via Establishment of a Disease Registry
 

Am J Trop Med Hyg. 2022 Jun 13;107(1):198-203. doi: 10.4269/ajtmh.21-1013. Print 2022 Jul 13.

Malini B DeSilva 1 2, Ann Settgast 1 3 4 2, Ella Chrenka 1, Amy J Kodet 1, Patricia F Walker 1 3 2
 
100.Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection
 

Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00653-X.doi: 10.1016/j.cgh.2022.06.015. Online ahead of print.

Jordan J Feld 1, Wendy C King 2, Marc G Ghany 3, Kyong-Mi Chang 4, Norah Terrault 5, Robert P Perrillo 6, Mandana Khalili 7, Amanda S Hinerman 2, Harry LA Janssen 8, Anna S Lok 9, Hepatitis B Research Network (HBRN)
 
101.Hepatitis B e antigen and e antibody in a multi-ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years
 

J Viral Hepat. 2022 Jul 6. doi: 10.1111/jvh.13731. Online ahead of print.

David Mutimer 1 2, Ahmed Elsharkawy 1, Emma Hathorn 1, Selvi Arunkumar 3
 
102.Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation
 

Sarah P Hammond 1, Vincent T Ho 2, Francisco M Marty 3

Transplant Cell Ther. 2022 Jul;28(7):402.e1-402.e5. doi: 10.1016/j.jtct.2022.04.004.Epub 2022 Apr 10.
 
103.Occult Hepatitis B Virus Infection: An Update
 

Viruses. 2022 Jul 8;14(7):1504. doi: 10.3390/v14071504.

Carlo Saitta 1 2, Teresa Pollicino 3, Giovanni Raimondo 1 2
 
104.Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B
 

Lancet HIV. 2022 Aug;9(8):e585-e594. doi: 10.1016/S2352-3018(22)00123-0.Epub 2022 Jul 8.

Amir M Mohareb 1, Joseph Larmarange 2, Arthur Y Kim 3, Patrick A Coffie 4, Menan Gérard Kouamé 5, Anders Boyd 6, Kenneth A Freedberg 7, Emily P Hyle 8
 
105.Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance
 

Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00660-7.doi: 10.1016/j.cgh.2022.06.019. Online ahead of print.

Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6, HBRN HBV Novel Assays Group (Corporate authorship); Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
 
106.Integrated hepatitis B virus DNA maintains surface antigen production during antivirals
 

J Clin Invest. 2022 Jul 7;e161818. doi: 10.1172/JCI161818. Online ahead of print.

Tanner Grudda 1, Hyon S Hwang 2, Maraake Taddese 2, Jeffrey Quinn 2, Mark S Sulkowski 2, Richard K Sterling 3, Ashwin Balagopal 2, Chloe L Thio 1
 
107.Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScore
 

Liver Int. 2022 Jul 21. doi: 10.1111/liv.15372. Online ahead of print.

Cynthuja Thilakanathan 1 2, Tahrima Kayes 1, Julia Di Girolamo 1, Vi Nguyen 2, Anne Glass 1, Sicha Manandhar 1, Joseph Lawler 3, Chris Meredith 3, Michael Maley 2 4, Andrew Lloyd 5, Miriam T Levy 1 2
 
108.Health care costs related to hepatitis B in Finland are mostly due to chronic infections: a register-based study
 

Infect Dis (Lond). 2022 Jul 20;1-9. doi: 10.1080/23744235.2022.2082519. Online ahead of print.

Tanja Nieminen 1, Heini Salo 1, Markku Nurhonen 2, Tuija Leino 1
 
109.Hepatitis B Vaccination of Low Birth Weight Infants in Washington State
 

Am J Perinatol. 2022 Jul;39(9):980-986. doi: 10.1055/s-0040-1721372. Epub 2020 Nov 30.

Katarina Ost 1, Natalia V Oster 2, Elizabeth N Jacobson 3, M Patricia deHart 4, Janet A Englund 1 3, Annika M Hofstetter 1 3
 
110.Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion
 

J Hepatol. 2022 Jul 15;S0168-8278(22)02935-X. doi: 10.1016/j.jhep.2022.07.003.Online ahead of print.

George V Papatheodoridis 1, Vasileios Lekakis 1, Thodoris Voulgaris 2, Pietro Lampertico 3, Thomas Berg 4, Henry L Y Chan 5, Jia-Horng Kao 6, Norah Terrault 7, Anna S Lok 8, K Rajender Reddy 9
 
111.Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease
 

Pediatr Qual Saf. 2022 Jun 23;7(4):e570. doi: 10.1097/pq9.0000000000000570.eCollection 2022 Jul-Aug.

Megan Megan McNicol 1, Amy Donegan 2, Kate Hawa 3, Angelique E Boutzoukas 3, Barb Drobnic 2, Melanie Oates 2, Maudie Orraca-Tetteh 2, Hilary K Michel 2, Ross M Maltz 2, Jennifer L Dotson 2, Don Buckingham 4, Brendan Boyle 2, Monica I Ardura 5
 
112.Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection
 

J Hepatol. 2022 Jun 10;S0168-8278(22)00348-8. doi: 10.1016/j.jhep.2022.05.027.Online ahead of print.

Mark S Sulkowski 1, Kosh Agarwal 2, Xiaoli Ma 3, Tuan T Nguyen 4, Eugene R Schiff 5, Hie-Won L Hann 6, Douglas T Dieterich 7, Ronald G Nahass 8, James S Park 9, Sing Chan 10, Steven-Huy B Han 11, Edward J Gane 12, Michael Bennett 13, Katia Alves 14, Marc Evanchik 14, Ran Yan 14, Qi Huang 14, Uri Lopatin 14, Richard Colonno 14, Julie Ma 14, Steven J Knox 14, Luisa M Stamm 14, Maurizio Bonacini 15, Ira M Jacobson 9, Walid S Ayoub 16, Frank Weilert 17, Natarajan Ravendhran 18, Alnoor Ramji 19, Paul Yien Kwo 20, Magdy Elkhashab 21, Tarek Hassanein 22, Ho S Bae 23, Jacob P Lalezari 15, Scott K Fung 24, Man-Fung Yuen 25
 
113.Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination
 

Clin Infect Dis. 2022 May 20;ciac385. doi: 10.1093/cid/ciac385. Online ahead of print.

Robert J Wong 1 2, Harvey W Kaufman 3, Justin K Niles 3, Hema Kapoor 3, Robert G Gish 4
 
114.Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection
 

Aliment Pharmacol Ther. 2022 Aug;56(3):510-518. doi: 10.1111/apt.17040. Epub 2022 May 22.

Tahrima Kayes 1 2, Harry Crane 1 2, Allison Symonds 3, Julie Dumond 3, Mackenzie Cottrell 3, Julia Di Girolamo 1 2, Sicha Manandhar 1 2, Tien Huey Lim 4, Edward Gane 5, Angela Kashuba 3, Miriam T Levy 1 2 6
 
115.Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022
 

MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-846. doi: 10.15585/mmwr.mm7126a2.

Rebecca J Free, Marilyn E Levi, James S Bowman, Danae Bixler, John T Brooks, Kate Buchacz, Anne Moorman, James Berger, Sridhar V Basavaraju
 
116.Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years
 

Liver Int. 2022 Jun 26. doi: 10.1111/liv.15347. Online ahead of print.

Nicolette Veracruz 1, Robert G Gish 2, Ramsey Cheung 3 4, Amit S Chitnis 5, Robert J Wong 3 4
 
117.Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis
 

J Gastroenterol Hepatol. 2022 May;37(5):782-794. doi: 10.1111/jgh.15783.Epub 2022 Feb 7.

Bao-Hong Yuan 1, Ru-Hong Li 1, Rong-Rui Huo 2, Min-Jun Li 2, George Papatheodoridis 3, Jian-Hong Zhong 2
 
118.Heplisav-B in Prior Hepatitis B Vaccine Nonresponders: A Case Series
 

Mil Med. 2022 Jul 1;187(7-8):e811-e813. doi: 10.1093/milmed/usab397.

Alan L Williams 1
 
119.Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients
 

Infect Dis. 2022 Jun 1;225(11):1974-1981. doi: 10.1093/infdis/jiab596.

Chien-Hung Chen 1, Cheng-Yuan Peng 2 3, Yuan-Hung Kuo 1, Tsung-Hui Hu 1, Chao-Hung Hung 1, Jing-Houng Wang 1, Sheng-Nan Lu 1
 
120.Hepatitis B Core Antibody Positivity Associated with Increased Risk of Liver Cancer in Patients with Chronic Hepatitis C: Analysis of a Large Patient Cohort in Hawai'i
 

Hawaii J Health Soc Welf. 2022 May;81(5):127-133.

Olivia A Collis 1, Patrycja A Ashley 2, Li-Hsieh Chen 2, Kathryn L Pedula 3, Shelley M Miyashiro 4, Shellie K Yamashita 4
 
121.Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019
 

JAMA Netw Open. 2022 Jun 1;5(6):e2219170. doi: 10.1001/jamanetworkopen.2022.19170.

Kathleen N Ly 1, Shaoman Yin 1, Philip R Spradling 1
 
122.Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis
 

Dig Dis Sci. 2022 Jun;67(6):2646-2654. doi: 10.1007/s10620-021-07056-5.Epub 2021 May 30.

Jennie Chen 1 2, Ashley Hubbard 3, Laurie Bagley 3 4, Rita Shiau 5, Robert J Wong # 6 7, Amit S Chitnis # 1
 
123.A Rapid Review of Interventions to Increase Hepatitis B Testing, Treatment, and Monitoring among Migrants Living in Australia
 

Int J Environ Res Public Health. 2022 May 13;19(10):5947.doi: 10.3390/ijerph19105947.

Vishnupriya Rajkumar 1, Kahlia McCausland 1 2, Roanna Lobo 1 2
 
124.Viral hepatitis in pregnancy
 

J Viral Hepat. 2022 Jun 24. doi: 10.1111/jvh.13725. Online ahead of print.

Mohamed Tarek M Shata 1, Helal F Hetta 1 2, Yeshika Sharma 1, Kenneth E Sherman 1
 
125.Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
 

Liver Int. 2022 Jun 29. doi: 10.1111/liv.15352. Online ahead of print.

Ferenci Peter 1, Reiberger Thomas 1, Stadlbauer Vanessa 2, Zoller Heinz 3
 
126.Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
 

World J Gastroenterol. 2022 Jun 7;28(21):2251-2281. doi: 10.3748/wjg.v28.i21.2251.

Leonardo Stella 1, Francesco Santopaolo 1, Antonio Gasbarrini 1, Maurizio Pompili 1, Francesca Romana Ponziani 2
 
127.A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV 'cure'
 

J Hepatol. 2022 Jul;77(1):245-248. doi: 10.1016/j.jhep.2022.03.006.Epub 2022 Mar 28.

Kosh Agarwal 1, James Lok 2, Ivana Carey 2, Yatin Shivkar 3, Michael Biermer 3, Thomas Berg 4, Isabelle Lonjon-Domanec 3
 
128.Novel therapeutic strategies for Chronic Hepatitis B
 

Virulence. 2022 Jun 28. doi: 10.1080/21505594.2022.2093444.Online ahead of print.

Sandra Phillips 1, Ravi Jagatia 1, Shilpa Chokshi 1
 
129.Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis
 

JAMA Netw Open. 2022 Jun 1;5(6):e2219407.doi: 10.1001/jamanetworkopen.2022.19407.

Darren Jun Hao Tan 1, Cheng Han Ng 1, Phoebe Wen Lin Tay 1, Nicholas Syn 1, Mark D Muthiah 1 2 3, Wen Hui Lim 1, Ansel Shao Pin Tang 1, Kai En Lim 1, Grace En Hui Lim 4, Nobuharu Tamaki 5, Beom Kyung Kim 5 6 7, Margaret Li Peng Teng 1 2 3, James Fung 8, Rohit Loomba 9, Mindie H Nguyen 10, Daniel Q Huang 1 2 3 9
 
130.The dilemma of cytomegalovirus and hepatitis B virus interaction
 

Gastroenterol Rep (Oxf). 2022 May 26;10:goac018. doi: 10.1093/gastro/goac018.eCollection 2022.

Muzammil M Khan 1, Mukarram J Ali 1, Hira Hanif 1, Muhammad H Maqsood 1, Imama Ahmad 2, Javier E G Alvarez 1, Maria-Andreea Catana 1, Daryl T Y Lau 1
 
131.Review article: Novel biomarkers in hepatitis B infection
 

Aliment Pharmacol Ther. 2022 Jun 30. doi: 10.1111/apt.17105. Online ahead of print.

James Lok 1, Geoffrey Dusheiko 1, Ivana Carey 1, Kosh Agarwal 1
 
132.Immunological insights in the treatment of chronic hepatitis B
 

Curr Opin Immunol. 2022 May 16;77:102207. doi: 10.1016/j.coi.2022.102207.Online ahead of print.

Matteo Iannacone 1, Francesco Andreata 2, Luca G Guidotti 3
 
133.Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
 

Aliment Pharmacol Ther. 2022 May 6. doi: 10.1111/apt.16968. Online ahead of print.

Samuel A L Hall 1 2, Gareth S Burns 1 2, Despina Anagnostou 1, Sara Vogrin 2, Vijaya Sundararajan 2 3, Dilip Ratnam 4 5, Miriam T Levy 6, John S Lubel 7 8, Amanda J Nicoll 9, Simone I Strasser 10 11, William Sievert 4 5, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, D Scott Bowden 17, Stephen A Locarnini 17, Kumar Visvanathan 1 2, Alexander J Thompson 1 2
 
134.How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
 

J Hepatol. 2022 Jun;76(6):1249-1262. doi: 10.1016/j.jhep.2021.11.024.

Grace L H Wong 1, Ed Gane 2, Anna S F Lok 3
 
135.Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review
 

Lancet Gastroenterol Hepatol. 2022 May 13;S2468-1253(22)00050-4.doi: 10.1016/S2468-1253(22)00050-4. Online ahead of print.

Catharina J Alberts 1, Gary M Clifford 2, Damien Georges 2, Francesco Negro 3, Olufunmilayo A Lesi 4, Yvan J-F Hutin 5, Catherine de Martel 2
 
136.Acute hepatitis B in pregnancy with surprisingly rapid clearance of serum HBs antigen associated with a favourable outcome
 

Int J Infect Dis. 2022 May;118:141-143. doi: 10.1016/j.ijid.2022.02.053.Epub 2022 Feb 27.

Steven Roger 1, Julien Fontana 2, Alexandra Ducancelle 3, Hélène Le Guillou-Guillemette 3, Clémence M Canivet 4, Caroline Lefeuvre 5
 
137.Australian consensus recommendations for the management of hepatitis B
 

Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6.

John S Lubel 1 2, Simone I Strasser 3 4, Alexander J Thompson 5 6, Benjamin C Cowie 7 8, Jennifer MacLachlan 7, Nicole L Allard 6 7, Jacinta Holmes 5 6, William W Kemp 1, Avik Majumdar 3, David Iser 5, Jess Howell 2 6 9, Gail V Matthews 10 11
 
138.The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives
 

Int J Equity Health. 2022 May 31;21(1):77.doi: 10.1186/s12939-022-01677-6.

Catherine Freeland 1, Lindsay Mendola 2, Vivian Cheng 3, Chari Cohen 4, Jack Wallace 5 6 7
 
139.Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness
 

Open Forum Infect Dis. 2022 Apr 7;9(5):ofac175. doi: 10.1093/ofid/ofac175.eCollection 2022 May.

Diana Partida 1, Jesse Powell 2, Daniel Gonzalez 1, Mandana Khalili 1
 
140.Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
 

Clin Drug Investig. 2022 May 28. doi: 10.1007/s40261-022-01163-5. Online ahead of print.

Matteo Megna 1, Cataldo Patruno 2, Maria Rita Bongiorno 3, Alessio Gambardella 4, Claudio Guarneri 5, Paolo Romita 6, Annunziata Raimondo 7, Francesco Loconsole 6, Gabriella Fabbrocini 8
 
141.Adult immunization against hepatitis B: Does the number of jabs matter?
 

Vaccine. 2022 Jun 9;40(26):3597-3604. doi: 10.1016/j.vaccine.2022.04.080. Epub 2022 May 12.

Gerry Oster 1, Rebecca Bornheimer 2, Kevin Ottino 2, Catherine Stevenson 3, Clem Lewin 4, Robert Janssen 3
 
142.Hepatitis B Virus-Associated Hepatocellular Carcinoma
 

Viruses. 2022 May 7;14(5):986. doi: 10.3390/v14050986.

Giacomo Emanuele Maria Rizzo 1 2 3, Giuseppe Cabibbo 1, Antonio Craxì 1
 
143.The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
 

Vaccines (Basel). 2022 May 17;10(5):793. doi: 10.3390/vaccines10050793.

Joan Ericka Flores 1 2, Alexander J Thompson 1 2 3, Marno Ryan 1 2 3, Jessica Howell 1 2 3 4
 
144.HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist
 

J Hepatol. 2022 Apr 7;S0168-8278(22)00175-1. doi: 10.1016/j.jhep.2022.03.007.Online ahead of print.

Francesco Paolo Russo 1, Mauro Viganò 2, Peter Stock 3, Alberto Ferrarese 4, Nicola Pugliese 5, Patrizia Burra 6, Alessio Aghemo 5
 
145.HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
 

Viruses. 2022 Mar 22;14(4):657. doi: 10.3390/v14040657.

Maryam Moini 1, Scott Fung 2
 
146.Care of the Hepatology Patient in the COVID-19 Era
 

Curr Hepatol Rep. 2022 Apr 1;1-12. doi: 10.1007/s11901-021-00581-x.Online ahead of print.

Kathryn E Driggers 1, Brett W Sadowski 2, Eva Shagla 3, Ryan M Kwok 4
 
147.Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
 

Pathogens. 2022 May 11;11(5):567. doi: 10.3390/pathogens11050567.

Caterina Sagnelli 1, Antonello Sica 2, Massimiliano Creta 3, Alessandra Borsetti 4, Massimo Ciccozzi 5, Evangelista Sagnelli 1
 
148.Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes
 

Liver Int. 2022 Mar 21.doi: 10.1111/liv.15249. Online ahead of print.

Golasa Samadi Kochaksaraei 1, Abdel A Shaheen 1 2, Cynthia H Seow 1 2, Herman W Barkema 2 3, Carla S Coffin 1
 
149.Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data
 

Aliment Pharmacol Ther. 2022 Apr;55(8):921-943. doi: 10.1111/apt.16788.Epub 2022 Feb 17.

Young-Suk Lim 1, Wai-Kay Seto 2 3, Masayuki Kurosaki 4, Scott Fung 5, Jia-Horng Kao 6, Jinlin Hou 7, Stuart C Gordon 8, John F Flaherty 9, Leland J Yee 9, Yang Zhao 9, Kosh Agarwal 10, Pietro Lampertico 11 12
 
150.Risk of HBV reactivation during therapies for HCC: A systematic review
 

Hepatology. 2022 May;75(5):1257-1274. doi: 10.1002/hep.32241. Epub 2021 Dec 16.

Margarita Papatheodoridi 1, Maria Tampaki 2, Anna S Lok 3, George V Papatheodoridis 2
 
151.Hepatitis B Virus Genotype G: The Odd Cousin of the Family
 

Front Microbiol. 2022 Mar 31;13:872766. doi: 10.3389/fmicb.2022.872766.eCollection 2022.

Natalia M Araujo 1, Carla Osiowy 2
 
152.Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection
 

JHEP Rep. 2022 Apr 2;4(6):100480. doi: 10.1016/j.jhepr.2022.100480.eCollection 2022 Jun.

Tobias Boettler 1, Upkar S Gill 2, Lena Allweiss 3 4, Teresa Pollicino 5, John E Tavis 6, Fabien Zoulim 7
 
153.Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease
 

Am J Gastroenterol. 2022 Feb 1;117(2):253-263.doi: 10.14309/ajg.0000000000001575.

Patrice Cacoub 1 2 3 4, Tarik Asselah 5 6
 
154.Clearance of hepatitis B "e" antigen in untreated chronic HBV infection: a systematic review and meta-analysis
 

J Infect Dis. 2022 May 2;jiac168. doi: 10.1093/infdis/jiac168. Online ahead of print.

Amir M Mohareb 1 2 3, Anne F Liu 3 4, Arthur Y Kim 2 3, Patrick A Coffie 5 6, Menan Gérard Kouamé 6, Kenneth A Freedberg 1 2 3 7, Anders Boyd 8 9, Emily P Hyle 1 2 3
 
155.Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort
 

Liver Transpl. 2022 Jan;28(1):39-50. doi: 10.1002/lt.26187. Epub 2021 Jul 20.

Natalie Z Wong 1, K Rajender Reddy 2, Therese Bittermann 2 3
 
156.Adefovir for lamivudine-resistant hepatitis B
 

Antivir Ther. 2022 Apr;27(2):13596535211067605.doi: 10.1177/13596535211067605.

Rebecca Roediger 1, Elizabeth Kula Smyth 2, Douglas Dieterich 1
 
157.Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature
 

Rev Med Virol. 2022 Apr 20;e2353. doi: 10.1002/rmv.2353. Online ahead of print.

Ahmed M Afifi 1, Anas Elgenidy 2, Mahmoud Hashim 3, Ahmed K Awad 4, Prasun K Jalal 5
 
158.Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy
 

Hepatol Int. 2022 Apr;16(2):211-253. doi: 10.1007/s12072-021-10285-5.Epub 2022 Feb 3.

Manoj Kumar 1, Zaigham Abbas 2, Milad Azami 3, Maria Belopolskaya 4, A K Dokmeci 5, Hasmik Ghazinyan 6, Jidong Jia 7, Ankur Jindal 8, Han Chu Lee 9, Wei Lei 10, Seng Gee Lim 11, Chun-Jen Liu 12, Qiang Li 13, Mamun Al Mahtab 14, David H Muljono 15, Madunil Anuk Niriella 16, Masao Omata 17 18, Diana A Payawal 19, Shiv K Sarin 20, Olivier Ségéral 21, Tawesak Tanwandee 22, Nirupma Trehanpati 23, Kumar Visvanathan 24, Jin Mo Yang 25, Man-Fung Yuen 26, Yingjie Zheng 27, Y H Zhou 28
 
159.Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine
 

Hum Vaccin Immunother. 2021 Nov 2;17(11):4567-4577. doi: 10.1080/21645515.2021.1965807.Epub 2021 Sep 10.

Catherine Stevenson 1, Ji-Hee Youn 2, Mary S Hayney 3, Coline David 1
 
160.Hepatitis B and Health Care Workers
 

Clin Liver Dis. 2021 Nov;25(4):859-874. doi: 10.1016/j.cld.2021.06.010.Epub 2021 Sep 11.

Stephen C Pappas 1
 
161.The viral hepatitis B care cascade: A population-based comparison of immigrant groups
 

Hepatology. 2022 Mar;75(3):673-689. doi: 10.1002/hep.32162. Epub 2021 Dec 7.

Abdool S Yasseen 1 2 3, Jeffrey C Kwong 1 2 3 4 5, Jordan J Feld 1 2 4 6, Rafal Kustra 1, Liane MacDonald 1 3, Christina C Greenaway 7 8 9, Naveed Z Janjua 10, Tony Mazzulli 3 4, Morris Sherman 4, Lauren Lapointe-Shaw 2 4 6, Beate Sander 1 2 3 4, Natasha S Crowcroft 1 2 3
 
162.Cure everyone and vaccinate the rest: The patient perspective on future hepatitis B treatment
 

J Viral Hepat. 2021 Nov;28(11):1539-1544. doi: 10.1111/jvh.13592. Epub 2021 Aug 11.

Catherine Freeland 1, Rhea Racho 1, Maureen Kamischke 1, Kate Moraras 1, Evangeline Wang 1, Chari Cohen 1
 
163.Hepatitis B-Associated Lupus-Like Glomerulonephritis Successfully Treated With Antiretroviral Drugs and Prednisone: A Case Report and Literature Review
 

J Investig Med High Impact Case Rep. Jan-Dec 2022;10:23247096221086451.doi: 10.1177/23247096221086451.

Sasmit Roy 1, Rohan Gupta 2, Sreedhar Adapa 3, Subhashish Bose 1, Amarinder Garcha 3
 
164.Drugs of Abuse and Their Impact on Viral Pathogenesis
 

Viruses. 2021 Nov 29;13(12):2387. doi: 10.3390/v13122387.

Jason T Blackard 1 2, Kenneth E Sherman 1 2
 
165.Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti-Tumor Necrosis Factor Therapy
 

Clin Gastroenterol Hepatol. 2022 Feb 18;S1542-3565(22)00183-5.doi: 10.1016/j.cgh.2022.02.027. Online ahead of print.

Shiva Poola 1, Marykate Kratzer 2, Sirish Sanaka 3, Kerry Sewell 4, Hans L Tillmann 5
 
166.Prevalence of hepatitis B surface antigen and hepatitis B core antibody among adults with latent tuberculosis infection
 

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e610-e614.doi: 10.1097/MEG.0000000000002180.

Ashley Hubbard 1, Grishma Hirode 2, Amit Chitnis 3, Robert Wong 4 5
 
167.Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection
 

J Antimicrob Chemother. 2022 Mar 31;77(4):1102-1110.doi: 10.1093/jac/dkab491.

Ed J Gane 1, Christian Schwabe 2, Elina Berliba 3 4, Pisit Tangkijvanich 5, Alina Jucov 3 4, Nelea Ghicavii 3, Thierry Verbinnen 6, Oliver Lenz 6, Willem Talloen 6, Thomas N Kakuda 7, Chris Westland 7, Megha Patel 7, Jeysen Z Yogaratnam 7, Leonard Dragone 7, Pieter Van Remoortere 8
 
168.Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019
 

J Viral Hepat. 2022 May;29(5):352-365. doi: 10.1111/jvh.13663. Epub 2022 Mar 15.

Nicolette Veracruz 1, Robert G Gish 2, Ramsey Cheung 3 4, Amit S Chitnis 5, Robert J Wong 3 4
 
169.The impact of hepatitis B vaccination in the United States, 1999-2018
 

Hepatology. 2021 Dec 2. doi: 10.1002/hep.32265. Online ahead of print.

Wen-Qiang He 1, Guan Nan Guo 1 2, Chenxi Li 1
 
170.Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study
 

J Viral Hepat. 2021 Dec;28(12):1690-1698. doi: 10.1111/jvh.13608.Epub 2021 Sep 29.

Robin Erken 1, Patrice Andre 2, Elise Roy 3, Neeltje Kootstra 4, Noelie Barzic 3, Hugo Girma 3, Christian Laveille 5, Pauline Radreau-Pierini 3, Raphael Darteil 3, Jacky Vonderscher 3, Pietro Scalfaro 3, Pisit Tangkijvanich 6, Robert Flisiak 7, Henk Reesink 8
 
171.Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment
 

J Patient Rep Outcomes. 2021 Nov 10;5(1):121. doi: 10.1186/s41687-021-00398-8.

Catherine Freeland 1, Rhea Racho 2, Maureen Kamischke 2, Kate Moraras 2, Evangeline Wang 2, Chari Cohen 2, Stuart Kendrick 3
 
172.Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner
 

Vaccine. 2022 Feb 23;40(9):1334-1341.doi: 10.1016/j.vaccine.2022.01.005. Epub 2022 Jan 31.

Laure F Pittet 1, Lianne Cox 2, Bridget Freyne 3, Susie Germano 4, Rhian Bonnici 5, Kaya Gardiner 6, Susan Donath 7, Clare L Collins 8, Dan Casalaz 9, Roy Robins-Browne 10, Katie L Flanagan 11, Nicole L Messina 12, Nigel Curtis 13
 
173.Circulating hepatitis B virus RNA: From biology to clinical applications
 

Hepatology. 2022 Mar 28. doi: 10.1002/hep.32479. Online ahead of print.

Rui Deng 1, Shi Liu 1, Sheng Shen 1 2, Haitao Guo 2, Jian Sun 1
 
174.An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus
 

J Clin Gastroenterol. 2022 Apr 7. doi: 10.1097/MCG.0000000000001695. Online ahead of print.

Ira M Jacobson 1, Robert S Brown Jr 2, Brian J McMahon 3 4 5, Robert P Perrillo 6, Robert Gish 7 8 9
 
175.The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
 

Clin Gastroenterol Hepatol. 2022 Mar 8;S1542-3565(22)00214-2.doi: 10.1016/j.cgh.2022.02.056. Online ahead of print.

Jennifer R Kramer 1, Peter A Richardson 1, Hyunseok Kim 2, Yao-Chun Hsu 2, Fasiha Kanwal 3, Hashem B El-Serag 4
 
176.Incidence of malignancies among patients with chronic hepatitis B in US health care organizations, 2006-2018
 

J Infect Dis. 2022 Jan 17;jiac011. doi: 10.1093/infdis/jiac011. Online ahead of print.

Philip R Spradling 1, Jian Xing 1, Y Zhong 1, Loralee B Rupp 2, Anne C Moorman 1, Mei Lu 2, Eyasu H Teshale 1, Mark A Schmidt 3, Yihe G Daida 4, Joseph A Boscarino 5, Stuart C Gordon 2 6, Chronic Hepatitis Cohort Study (CHeCS) Investigators
 
177.Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection
 

J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.

Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
 
178.Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose
 

Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.

Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
 
179.Review article: hepatitis B-current and emerging therapies
 

Aliment Pharmacol Ther. 2022 Apr;55(7):805-819. doi: 10.1111/apt.16828.Epub 2022 Feb 27.

David Yardeni 1, Marc G Ghany 1
 
180.Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection
 

J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.

Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
 
181.Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose
 

Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.

Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
 
182.Review article: hepatitis B-current and emerging therapies
 

Aliment Pharmacol Ther. 2022 Apr;55(7):805-819. doi: 10.1111/apt.16828.Epub 2022 Feb 27.

David Yardeni 1, Marc G Ghany 1
 
183.Serological testing on the ADVIA Centaur system for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in specimens from deceased and living individuals demonstrates equivalent results l
 

Transpl Infect Dis. 2022 Feb 17;e13802. doi: 10.1111/tid.13802. Online ahead of print.

Theodore B Wright 1, Sai Patibandla 1, Renee Walsh 1, Rachel Fonstad 1, Matthew Gee 1, Vera Bitcon 1, Julie Hopper 2, Susie J Braniff 3, Susan Best 3, Scott Read 4
 
184.Assessing the cost-utility of universal hepatitis B vaccination among adults
 

J Infect Dis. 2022 Mar 9;jiac088. doi: 10.1093/infdis/jiac088. Online ahead of print.

Eric W Hall 1 2, Mark K Weng 3, Aaron M Harris 3, Sarah Schillie 4, Noele P Nelson 3, Ismael R Ortega-Sanchez 4, Elizabeth Rosenthal 5, Patrick S Sullivan 2, Ben Lopman 2, Jeb Jones 2, Heather Bradley 6, Eli S Rosenberg 5 7
 
185.Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis
 

Hepatology. 2022 Jan 31. doi: 10.1002/hep.32380. Online ahead of print.

Heejoon Jang 1 2, Yun Bin Lee 1, Hyemi Moon 3, Jong-Won Chung 4, Joon Yeul Nam 1, Eun Ju Cho 1, Jeong-Hoon Lee 1, Su Jong Yu 1, Yoon Jun Kim 1, Juneyoung Lee 3, Jung-Hwan Yoon 1
 
186.Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks
 

AIDS. 2022 Feb 14. doi: 10.1097/QAD.0000000000003193. Online ahead of print.

Claudia Hawkins 1, Minhee Kang, Debika Bhattacharya, Gavin Cloherty, Mary Kuhns, Roy Matining, Chloe Thio, Wadzanai Samaneka, Lameck Chinula, Nyirenda Mulinda, Sharlaa Badal-Faesen, Patcharaphan Sugandhavesa, Javier Lama, Simani Gaseitsiwe, Vera Holzmayer, Mark Anderson, Robert Murphy, Marion Peters
 
187.Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naïve Chronic Hepatitis B Patients
 

Dig Dis Sci. 2022 Mar 4. doi: 10.1007/s10620-022-07402-1. Online ahead of print.

Sammy Saab 1 2, Nguyen Pham 3, William Wu 3 4, Long Dang 3, An Dang 3, Jung Yum 3, Kisub Shim 3, Steven Wu 4
 
188.Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults
 

Dig Dis Sci. 2022 Feb;67(2):676-688. doi: 10.1007/s10620-021-06860-3. Epub 2021 Feb 8.

Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, David E Kleiner 4, Amanda S Hinerman 2, Mark Sulkowski 5, Raymond T Chung 6, Mamta K Jain 7, M Auricio Lisker-Melman 8, David K Wong 9, Marc G Ghany 4, HBV-HIV Cohort Study of the Hepatitis B Research Network
 
189.Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada
 

J Pediatr. 2021 Oct;237:24-33.e12. doi: 10.1016/j.jpeds.2021.05.035.Epub 2021 May 20.

Simon C Ling 1, Hsing-Hua S Lin 2, Karen F Murray 3, Philip Rosenthal 4, Douglas Mogul 5, Norberto Rodriguez-Baez 6, Sarah Jane Schwarzenberg 7, Jeffrey Teckman 8, Kathleen B Schwarz 5, Hepatitis B Research Network (HBRN)

Hepatitis B Research Network (HBRN): 

Hongxia Li, Robert Anders, Hejab Imteyaz, Peter Lee, Kiyoko Oshima, Kim Kafka, Naureen Islam, Shannon M Riggs, Rosemary A Nagy, Jacki Cerkoski, Athena Hau, Daniel Cui, Laurie A Rodgers-Augustyniak, Shirley Montanye, Natasha Feier, Joel Feier, Camille Langlois, Kara L Cooper, Jay H Hoofnagle, Averell H Sherker, Edward Doo, Rebecca J Torrance, Sherry R Hall, Frani Averbach, Tamara Haller, Regina Hardison, Stephanie Kelley, Christina M Lalama, Sharon Lawlor, Manuel Lombardero, Andrew Pelesko, Donna Stoliker, Melissa Weiner, Ella Zadorozny, Qian Zhao
 
190.Changes in serum hepatitis B surface and e antigen, IP-10, and aminotransferase levels during combination therapy of immune tolerant chronic hepatitis B
 

Hepatology. 2022 Feb 21. doi: 10.1002/hep.32400. Online ahead of print.

Robert P Perrillo 1, Hsing-Hua S Lin 2, Kathleen B Schwarz 3, Philip Rosenthal 4, Mauricio Lisker-Melman 5, Raymond T Chung 6, Ludmila Prokunina-Olsson 7, Gavin Coherty 8, Jordan Feld 9, Hepatitis B Research Network (HBRN)
 
191.Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B
 

Hepatology. 2022 Jan 24. doi: 10.1002/hep.32352. Online ahead of print.

Robin Erken 1 2, Vladimir Loukachov 1, Karel van Dort 1, Anne van den Hurk 1, R Bart Takkenberg 2, Anniki de Niet 2, Louis Jansen 2, Sophie Willemse 2, Henk Reesink 3, Neeltje Kootstra 1
 
192.Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014
 

Infect Control Hosp Epidemiol. 2021 Dec;42(12):1458-1463. doi: 10.1017/ice.2021.31.Epub 2021 Mar 1.

Stacy R Tressler 1, Maria C Del Rosario 1, Michelle D Kirby 2, Ashley N Simmons 1, Melissa A Scott 1, Sherif Ibrahim 1, Joseph C Forbi 3, Hong Thai 3, Guo-Liang Xia 3, Meghan Lyman 4, Melissa G Collier 3, Priti R Patel 4, Danae Bixler 1
 
193.Evaluation of dried blood spots for hepatitis B and D serology and nucleic acid testing
 

J Med Virol. 2022 Feb;94(2):642-648. doi: 10.1002/jmv.25485. Epub 2019 Apr 24.

Kathy Jackson 1, Thomas Holgate 1, Rosemary Tekoaua 2, Suellen Nicholson 1, Margaret Littlejohn 1, Stephen Locarnini 1
 
194.Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
 

J Hepatol. 2022 Jan 26;S0168-8278(22)00020-4. doi: 10.1016/j.jhep.2022.01.007.Online ahead of print.

M J Sonneveld 1, S-M Chiu 2, J Y Park 3, S M Brakenhoff 4, A Kaewdech 5, W K Seto 6, Y Tanaka 7, I Carey 8, M Papatheodoridi 9, F van Bömmel 10, T Berg 11, F Zoulim 12, S H Ahn 13, G N Dalekos 14, N S Erler 15, C Höner Zu Siederdissen 16, H Wedemeyer 17, M Cornberg 18, M F Yuen 19, K Agarwal 20, A Boonstra 21, M Buti 22, T Piratvisuth 23, G Papatheodoridis 24, C-H Chen 25, B Maasoumy 26, CREATE study group
 
195.The Possible Protective Effect of Hepatitis B Vaccine Against Lymphomas: A Systematic Review
 

Curr Pharm Biotechnol. 2022 Jan 13. doi: 10.2174/1389201023666220113111946.Online ahead of print.

Lorenza Lia 1, Daniela Grima 1, Francesca Amici 1, Linda Manzi 1, Alessandro Monaci 1, Giuseppe La Torre 1
 
196.Envafolimab: First Approval
 

Drugs. 2022 Feb;82(2):235-240. doi: 10.1007/s40265-022-01671-w.

Anthony Markham 1
 
197.An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States
 

Hepatology. 2021 Aug;74(2):607-626. doi: 10.1002/hep.31782.Epub 2021 May 26.

Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
 
198.Getting to HBV cure: the promising paths forward
 

Hepatology. 2022 Jan 6. doi: 10.1002/hep.32314. Online ahead of print.

Scott Fung 1, Hannah S J Choi 1, Adam Gehring 1, Harry L A Janssen 1
 
199.Documentation of Hepatitis B Immunity in Nursing Students
 

Nurs Educ Perspect. 2022 Jan-Feb 01;43(1):55-56. doi: 10.1097/01.NEP.0000000000000736.

Julie Kientz Elting 1
 
200.Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be done
 

Dig Liver Dis. 2021 Oct;53(10):1315-1319. doi: 10.1016/j.dld.2020.10.011. Epub 2020 Nov 6.

Tommaso Stroffolini 1, Anna Lombardi 2, Alessia Ciancio 3, Rosanna Fontana 4, Guido Colloredo 5, Massimo Marignani 6, Maria Vinci 7, Filomena Morisco 8, Sergio Babudieri 9, Luigina Ferrigno 10, Evangelista Sagnelli 11
 
201.Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease
 

Dig Dis Sci. 2021 Jun;66(6):2101-2106.doi: 10.1007/s10620-020-06437-6. Epub 2020 Jul 2.

Waseem Amjad 1, Joseph Alukal 1, Talan Zhang 1, Anurag Maheshwari 1 2, Paul J Thuluvath 3 4
 
202.Moving towards core antigen for the management of patients with overt and occult HBV infection
 

Panminerva Med. 2021 Dec;63(4):499-507. doi: 10.23736/S0031-0808.20.04163-4.Epub 2020 Oct 19.

Angelo Armandi 1, Chiara Rosso 1, Davide G Ribaldone 1 2, Gian P Caviglia 3
 
203.Talking testing: Impact of a training intervention on midwives' antenatal HIV, hepatitis B and hepatitis C screening practice
 

Women Birth. 2021 Sep;34(5):e520-e525. doi: 10.1016/j.wombi.2020.10.001. Epub 2020 Nov 4.

Jen Johnson 1, Caroline Carr 2, Susan J McDonald 3, Margaret M Flood 4
 
204.Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists
 

J Pharm Pract. 2021 Dec;34(6):943-951. doi: 10.1177/0897190020958261.Epub 2020 Sep 17.

Michelle R Paulsen 1, Nikitha R Patel 2, Carol Sulis 3, Francis A Farraye 4, Shubha Bhat 2
 
205.Rapid, random-access, and quantification of hepatitis B virus using the Cepheid Xpert HBV viral load assay
 

Med Virol. 2021 Jun;93(6):3999-4003. doi: 10.1002/jmv.26392. Epub 2020 Aug 25.

Ali M Auzin 1, Serena Slavenburg 2, Cas Peters 1, Greet Boland 2, Janette Rahamat-Langendoen 1, Willem J G Melchers 1, Rob Schuurman 2
 
206.Critical Updates on Chronic Hepatitis B Virus Infection in 2021
 

Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152.eCollection 2021 Oct.

Cyriac A Philips 1, Rizwan Ahamed 2, Jinsha K Abduljaleel 2, Sasidharan Rajesh 3, Philip Augustine 2
 
207.Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
 

Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.

Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
 
208.New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection
 

Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011.Epub 2021 Aug 8.

Lisa Sandmann 1, Heiner Wedemeyer 2
 
209.Critical Updates on Chronic Hepatitis B Virus Infection in 2021
 

Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152.eCollection 2021 Oct.

Cyriac A Philips 1, Rizwan Ahamed 2, Jinsha K Abduljaleel 2, Sasidharan Rajesh 3, Philip Augustine 2
 
210.Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
 

Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.

Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
 
211.New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection
 

Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011.Epub 2021 Aug 8.

Lisa Sandmann 1, Heiner Wedemeyer 2
 
212.Should Treatment Indications for Chronic Hepatitis B Be Expanded?
 

Clin Gastroenterol Hepatol. 2021 Oct;19(10):2006-2014.doi: 10.1016/j.cgh.2020.04.091. Epub 2020 May 17.

Wen-Juei Jeng 1, Anna S Lok 2
 
213.Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients
 

J Rheumatol. 2021 Aug;48(8):1314-1321. doi: 10.3899/jrheum.200283. Epub 2020 Aug 1.

Najla Aljaberi 1, Enas Ghulam 2, Emily A Smitherman 3, Leslie Favier 4, Dana M H Dykes 5, Lara A Danziger-Isakov 6, Rebecca C Brady 6, Jennifer Huggins 7
 
214.Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
 

Clin Infect Dis. 2021 Jun 1;72(11):2029-2031. doi: 10.1093/cid/ciaa1015.

Mark Anderson 1, Jeffery Gersch 1, Ka-Cheung Luk 1, George Dawson 1, Ivana Carey 2, Kosh Agarwal 3, Pir Shah 4, Geoffrey Dusheiko 3, Daryl Lau 4, Gavin Cloherty 1
 
215.Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection
 

Clin Gastroenterol Hepatol. 2021 Sep;19(9):1933-1940.e1. doi: 10.1016/j.cgh.2020.09.004.Epub 2020 Sep 3.

Hannah S J Choi 1, Margo J H van Campenhout 2, Anneke J van Vuuren 2, Lisette A P Krassenburg 3, Milan J Sonneveld 2, Robert J de Knegt 2, Bettina E Hansen 4, Harry L A Janssen 5
 
216.Use of Electronic Health Records at Federally Qualified Health Centers: a Potent Tool to Increase Viral Hepatitis Screening and Address the Climbing Incidence of Liver Cancer
 

J Cancer Educ. 2021 Oct;36(5):1093-1097. doi: 10.1007/s13187-020-01741-1.

Christina Pham 1, Mo-Kyung Sin 2
 
217.Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time
 

Hepatology. 2021 Jun;73(6):2141-2154. doi: 10.1002/hep.31557. Epub 2021 Jun 15.

Lauren Lapointe-Shaw 1 2 3 4 5, Hannah Chung 3, Laura Holder 3, Jeffrey C Kwong 3 4 6 7 8, Beate Sander 2 3 4 6 9 10, Peter C Austin 3 10, Harry L A Janssen 1 2 4 11, Jordan J Feld 1 2 4 11
 
218.Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
 

Hepatology. 2021 Jun;73(6):2124-2140. doi: 10.1002/hep.31554. Epub 2021 May 21.

Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)
 
219.Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems
 

Am J Gastroenterol. 2021 Jul 1;116(7):1465-1475. doi: 10.14309/ajg.0000000000001195.

Robert J Wong 1 2 3, Mamta K Jain 4 5, George Therapondos 6, Bolin Niu 7, Onkar Kshirsagar 8, Mae Thamer 8
 
220.Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection
 

Intern Emerg Med. 2021 Sep 2. doi: 10.1007/s11739-021-02836-3. Online ahead of print.

Michele Barone 1, Vincenzo Venerito 2, Rosa Paolillo 1, Giacomo Emmi 3, Marco Fornaro 2, Fabio Cacciapaglia 2, Luca Cantarini 4, Alfredo Di Leo 1, Florenzo Iannone 2, Giuseppe Lopalco 5
 
221.Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
 

Front Med (Lausanne). 2021 Aug 20;8:706482. doi: 10.3389/fmed.2021.706482.eCollection 2021.

Cori Campbell 1, Monique I Andersson 2 3, M Azim Ansari 1 4, Olivia Moswela 5, Siraj A Misbah 6, Paul Klenerman 1 2, Philippa C Matthews 1 2
 
222.Towards eradication of HBV: Treatment approaches and status of clinical trials
 

Curr Opin Pharmacol. 2021 Aug 30;60:232-240. doi: 10.1016/j.coph.2021.07.008.Online ahead of print.

Lisa Sandmann 1, Markus Cornberg 2
 
223.Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis
 

Front Microbiol. 2021 Aug 6;12:695384. doi: 10.3389/fmicb.2021.695384.eCollection 2021.

Carla S Coffin 1, Patricia M Mulrooney-Cousins 2, Tomasz I Michalak 2
 
224.Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B
 

GastroHep. 2021 May;3(3):196-208. doi: 10.1002/ygh2.458. Epub 2021 May 5.

Donna M Evon 1, Hsing-Hua S Lin 2, Robert J Fontana 3, Mandana Khalili 4, Colina Yim 5, Abdus S Wahed 2, Jay H Hoofnagle 6
 
225.Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
 

Clin Gastroenterol Hepatol. 2021 Jul 27;S1542-3565(21)00818-1. doi: 10.1016/j.cgh.2021.07.036.Online ahead of print.

Paul Martin 1, Mindie H Nguyen 2, Douglas T Dieterich 3, Daryl T-Y Lau 4, Harry L A Janssen 5, Marion G Peters 6, Ira Jacobson 7
 
226.Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals
 

Aliment Pharmacol Ther. 2021 Jul 19. doi: 10.1111/apt.16524. Online ahead of print.

Jill Koshiol 1, Ilona Argirion 1, Zhiwei Liu 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly Yu 1, Katherine A McGlynn 1, Jessica L Petrick 1 3, Ligia Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Ruth M Pfeiffer 1, Mei-Hsuan Lee 7, Hwai-I Yang 5
 
227.The Inflammatory Cytokine Profile Associated with Liver Damage is Broader and Stronger in Chronic Hepatitis B Patients Compared to Acute Hepatitis B Patients
 

J Infect Dis. 2021 Jul 21;jiab373. doi: 10.1093/infdis/jiab373. Online ahead of print.

Alexandra Johnson Valiente 1 2, Kin Seng Liem 2 3, Kathleen B Schwarz 4 5, Philip Rosenthal 6, Karen F Murray 7, Douglas Mogul 5, Jeffery Teckman 8, Norberto Rodriguez-Baez 9, Sarah Jane Schwarzenberg 10, Jordan J Feld 2 11, David K Wong 2, Lia L Lewis-Ximenez 12, Georg Lauer 13, Bettina E Hansen 2 14, Simon C Ling 15 16, Harry L A Janssen 2 11, Adam J Gehring 1 2 11
 
228.Hepatitis B Virus (HBV) Genotype: A Significant Risk Factor in Determining which Patients with Chronic HBV Infection should Undergo Surveillance for Hepatocellular Carcinoma: The Hepatitis B Alaska (HEP-B-AK) Study
 

Hepatology. 2021 Jul 22. doi: 10.1002/hep.32065. Online ahead of print.

Brian J McMahon 1 2, Solu Nolen 2, Mary Snowball 1, Chriss Homan 1, Susan Negus 1, Elena Roik 1, Philip R Spradling 3, Dana Bruden 2
 
229.Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus
 

Pharmacoepidemiol Drug Saf. 2021 Jul 10. doi: 10.1002/pds.5327. Online ahead of print.

Katherine Wong 1, Katia Bruxvoort 1, Jeff Slezak 1, Jin-Wen Y Hsu 1, Kristi Reynolds 1, Lina S Sy 1, Steven J Jacobsen 1
 
230.Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
 

 

BMJ Case Rep. 2021 Jul 9;14(7):e243526. doi: 10.1136/bcr-2021-243526.

Branko Borojevic 1, Ayushi Chauhan 2, Scott Patterson 3
 
231.Hepatitis B Screening of At-Risk Immigrants Seen at Primary Care Clinics: A Quality Improvement Project
 

Mayo Clin Proc Innov Qual Outcomes. 2021 May 27;5(3):635-644.doi: 10.1016/j.mayocpiqo.2021.04.002. eCollection 2021 Jun.

Peace N Eneh 1, Mohamed Mady 1, Mikayla A Schmidt 1, Eneyew Tilahun 1, Fatima Hassan 1, Jane W Njeru 2, Sarah J Crane 2, Rajeev Chaudhry 2, Lewis R Roberts 1
 
232.Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example
 

Vaccine X. 2021 Jun 11;8:100101. doi: 10.1016/j.jvacx.2021.100101. eCollection 2021 Aug.

Katia Bruxvoort 1, Lina S Sy 1, Bradley K Ackerson 1, Jeff Slezak 1, Lei Qian 1, William Towner 1, Kristi Reynolds 1, Zendi Solano 1, Cheryl M Carlson 1, Steven J Jacobsen 1
 
233.A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States
 

Am J Gastroenterol. 2021 Jun 30. doi: 10.14309/ajg.0000000000001364. Online ahead of print.

Esperance A K Schaefer 1
 
234.Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001-2018
 

J Infect Dis. 2021 Jul 12;jiab366. doi: 10.1093/infdis/jiab366. Online ahead of print.

Philip R Spradling 1, Jian Xing 1, Aaron M Harris 1, Kathleen N Ly 1
 
235.Moving Fast Toward Hepatitis B Virus Elimination
 

Adv Exp Med Biol. 2021;1322:115-138. doi: 10.1007/978-981-16-0267-2_5.

Leda Bassit # 1, Suzane Kioko Ono # 2, Raymond F Schinazi 3
 
236.Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019
 

MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):961-966. doi: 10.15585/mmwr.mm7027a1.

Danae Bixler, Pallavi Annambhotla, Martha P Montgomery, Tonya Mixon-Hayden, Ben Kupronis, Marian G Michaels, Ricardo M La Hoz, Sridhar V Basavaraju, Saleem Kamili, Anne Moorman
 
237.Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States
 

J Immigr Minor Health. 2021 Jun 23. doi: 10.1007/s10903-021-01231-6.Online ahead of print.

Amit S Chitnis 1, Ramsey Cheung 2 3, Robert G Gish 4, Robert J Wong 2 3
 
238.Family imaginaries in the disclosure of a blood-borne virus
 

Sociol Health Illn. 2021 Jun 23. doi: 10.1111/1467-9566.13316. Online ahead of print.

Anthony K J Smith 1, Asha Persson 1, Kerryn Drysdale 1 2, Joanne Bryant 1, Kylie Valentine 3, Jack Wallace 4, Myra Hamilton 5, Rebecca M Gray 1, Christy E Newman 1
 
239.Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
 

BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.

Tingyan Wang 1 2, David A Smith 2 3, Cori Campbell 1 2, Jolynne Mokaya 1, Oliver Freeman 2 4, Hizni Salih 2 4, Anna L McNaughton 1, Sarah Cripps 5, Kinga A Várnai 2 3, Theresa Noble 2 3, Kerrie Woods 2 3, Jane Collier 6, Katie Jeffery 7, Jim Davies 2 8, Eleanor Barnes # 9 10, Philippa C Matthews # 11 12 13
 
240.Hepatitis B cure: How and when
 

Liver Int. 2021 Jun;41 Suppl 1:24-29.doi: 10.1111/liv.14837.

Geoffrey Dusheiko 1
 
241.Comparison of Novel Biomarkers with Conventional HBV Markers among Untreated Adults with Chronic Hepatitis B in North America
 

Hepatology. 2021 Jun 16. doi: 10.1002/hep.32018. Online ahead of print.

Marc G Ghany 1, Wendy C King 2, Mauricio Lisker-Melman 3, Anna Sf Lok 4, Norah Terrault 5, Harry L A Janssen 6, Mandana Khalili 7, Raymond T Chung 8, William M Lee 9, Daryl T Y Lau 10, Gavin A Cloherty 11, Richard K Sterling 12
 
242.Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?
 

Transfusion. 2021 Jun 11. doi: 10.1111/trf.16543. Online ahead of print.

Heli Harvala 1 2, Claire Reynolds 3, Zoë Gibney 4, Jade Derrick 5, Samreen Ijaz 5, Katy L Davison 4, Su Brailsford 1 3
 
243.Hepatitis B and Hepatitis C among Adults on Probation or Parole in the United States: 2015-2018
 

J Health Care Poor Underserved. 2021;32(2):671-679. doi: 10.1353/hpu.2021.0096.

Greta Kilmer, Elizabeth Hughes
 
244.Prevalence of Hepatitis B Virus (HBV) Infection, Vaccine-Induced Immunity, and Susceptibility among At-Risk Populations: U.S. Households, 2013-2018
 

Hepatology. 2021 Jun 7. doi: 10.1002/hep.31991. Online ahead of print.

Henry Roberts 1, Kathleen N Ly 1, Shaoman Yin 1, Elizabeth Hughes 1, Eyasu Teshale 1, Ruth Jiles 1
 
245.Covalently closed circular DNA: the ultimate therapeutic target for curing Hepatitis B virus infections
 

J Hepatol. 2021 May 26;S0168-8278(21)00348-2. doi: 10.1016/j.jhep.2021.05.013.Online ahead of print.

Maria Guadalupe Martinez 1, Anders Boyd 2, Emmanuel Combe 1, Barbara Testoni 1, Fabien Zoulim 3
 
246.Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV
 

Dig Dis Sci. 2021 May 31. doi: 10.1007/s10620-021-07033-y. Online ahead of print.

David E Bernstein 1, Huy N Trinh 2, Eugene R Schiff 3, Coleman I Smith 4, Andrea R Mospan 5, Richard C Zink 5, Michael W Fried 5, Anna S Lok 6
 
247.Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study
 

BMC Public Health. 2021 May 28;21(1):1004. doi: 10.1186/s12889-021-11093-0.

Catherine Freeland 1 2, Sean Farrell 3 4, Priyanka Kumar 3 5, Maureen Kamischke 6, Michaela Jackson 6, Sierra Bodor 6, Timothy M Block 6, Rosemary Frasso 3, Chari Cohen 6
 
248.An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States
 

Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782. Online ahead of print.

Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
 
249.Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems
 

J Clin Gastroenterol. 2021 Mar 17. doi: 10.1097/MCG.0000000000001530. Online ahead of print.

Robert J Wong 1, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer
 
250.Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease
 

Am J Med. 2021 Mar 26;S0002-9343(21)00159-5. doi: 10.1016/j.amjmed.2021.02.008. Online ahead of print.

Robert J Wong 1, Robert G Gish 2, Ramsey Cheung 3, Amit S Chitnis 4
 
251.Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems
 

Am J Gastroenterol. 2021 Mar 1. doi: 10.14309/ajg.0000000000001195. Online ahead of print.

Robert J Wong 1, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer
 
252.Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis
 

J Clin Gastroenterol. 2021 Apr 9. doi: 10.1097/MCG.0000000000001533. Online ahead of print.

Robert J Wong 1, Ashley Hubbard, Laurie Bagley, Rita Shiau, Amit S Chitnis
 
253.Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C
 

J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545. Online ahead of print.

Erika Duffell 1, Helena Cortez-Pinto 2, Marieta Simonova 3, Olav Dalgard 4, Elin Hoffmann Dahl 5, Catherine de Martel 6, Antons Mozalevskis 7, Maria Buti 8, Slava Pavlova 3, Tnaiq Hadzhilova 3, Carolina Simões 2, Krum Katzarov 3, Otilia Mardh 1
 
254.Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls
 

Nephrol Dial Transplant. 2021 May 17;gfab179. doi: 10.1093/ndt/gfab179. Online ahead of print.

Benedikt Simon 1, Harald Rubey 1, Andreas Treipl 2, Martin Gromann 2, Boris Hemedi 3, Sonja Zehetmayer 4, Bernhard Kirsch 2
 
255.Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study
 

Int J Dermatol. 2021 May 17. doi: 10.1111/ijd.15578. Online ahead of print.

Jeffrey M Cohen 1, Khalaf K Kridin 2, Lourdes M Perez-Chada 3, Joseph F Merola 3 4, Arnon D Cohen 5 6
 
256.Therapeutic vaccination for treatment of Chronic Hepatitis B
 

Clin Exp Immunol. 2021 May 9. doi: 10.1111/cei.13614. Online ahead of print.

Tamsin Cargill 1 2, Eleanor Barnes 1 2 3
 
257.High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
 

Microorganisms. 2021 Apr 30;9(5):968. doi: 10.3390/microorganisms9050968.

Jan-Hendrik Bockmann 1 2, Matin Kohsar 1, John M Murray 3, Vanessa Hamed 1, Maura Dandri 1 2, Stefan Lüth 4, Ansgar W Lohse 1 2, Julian Schulze-Zur-Wiesch 1 2

 
 
258.Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States
 

Clin Infect. 2021 May 6;ciab405.doi: 10.1093/cid/ciab405. Online ahead of print.

Mehlika Toy 1, David Hutton 2, Aaron M Harris 3, Noele Nelson 3, Joshua A Salomon 4, Samuel So 1
 
259.Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults
 

Dig Dis Sci. 2021 May 4. doi: 10.1007/s10620-021-07008-z. Online ahead of print.

Wen-Qiang He 1, Gail V Matthews 2, Bette Liu 3
 
260.Challenges in Formulation and Implementation of Hepatitis B Elimination Programs
 

Cureus. 2021 Apr 24;13(4):e14657. doi: 10.7759/cureus.14657.

Zaigham Abbas 1, Minaam Abbas 2
 
261.Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
 

Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi:10.1016/j.omtm.2021.03.012.eCollection 2021 Jun 11.

Gounwa Awad 1, Toralf Roch 1 2, Ulrik Stervbo 1, Sviatlana Kaliszczyk 1 2, Anna Stittrich 2 3, Jan Hörstrup 4, Ocan Cinkilic 5, Heiner Appel 6, Larysa Natrus 7, Ludmila Gayova 7, Felix Seibert 1, Frederic Bauer 1, Timm Westhoff 1, Mikalai Nienen 2 3 8, Nina Babel 1 2
 
262.Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018
 

J Infect Dis. 2021 Apr 27;jiab224. doi: 10.1093/infdis/jiab224. Online ahead of print.

Kathleen N Ly 1, Jian Xing 1, Philip R Spradling 1
 
263.Clinical Significance of Quantitative e Antigen in a Cohort of Hepatitis B Virus Infected Children and Adults in North America
 

J Viral Hepat. 2021 Apr 24. doi: 10.1111/jvh.13520. Online ahead of print.

Stewart L Cooper 1, Wendy C King 2, Douglas B Mogul 3, Marc G Ghany 4, Kathleen B Schwarz 3, Hepatitis B Research Network (HBRN)

 

  • Hepatitis B Research Network (HBRN):